5443062026-01-012026-03-315443062026-03-315443062025-03-315443062025-04-012026-03-315443062026-01-012026-03-31in-capmkt:OtherExpenses1Member5443062025-04-012026-03-31in-capmkt:OtherExpenses1Member5443062026-03-31OtherNoncurrentFinancialAssetsDomain15443062026-03-31OtherNoncurrentAssetsDomain15443062026-03-31OtherNoncurrentAssetsDomain25443062026-03-31OtherCurrentFinancialAssetsDomain15443062026-03-31OtherCurrentAssetsDomain15443062026-03-31OtherNoncurrentFinancialLiabilitiesDomain15443062026-03-31OtherCurrentFinancialLiabilitiesDomain15443062026-03-31OtherCurrentFinancialLiabilitiesDomain25443062026-03-31OtherCurrentLiabilitiesDomain15443062026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15443062025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15443062026-01-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15443062026-01-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss25443062025-04-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15443062025-04-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss25443062026-01-012026-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares544306SAILIFENOTLISTEDINE570L01029SAI LIFE SCIENCES LIMITEDMain BoardEquity2025-04-012026-03-312026-05-142026-04-21INRMillionsQuarterlyFourth quarterSingle segmentContract Research, Development and Manufacturing (CRDMO)2026-05-1421:05:002026-05-1421:44:00trueCash Flow IndirectDeclaration of unmodified opinion2026-01-012026-03-31UnauditedConsolidated60213900001551900006176580000159186000002521000018665400007825000045308000077229000047872300001389350000292000013922700001327800002171300003499100000104236000000001042360000-9114000095122000021178000014.934.87004.934.87NA2025-04-012026-03-31AuditedConsolidated219249200004912800002241620000057811500000-72230000683055000039239000016685500003073860000176742700004741930000-80010000466192000088402000028880000011728200000348910000000003489100000-208220000328088000021178000012462510000016.6316.430016.6316.43Other Expenses772290000Other Expenses307386000018087150000270453000006117000035100000057769000061279000013435000055611000022156100000150968000046992000037362300008191400002895700000103971000063545700006241050000141053000003626140000021178000024625100000248368800002483688000020504000012762000001481240000323180000128332000030877400007462100004295300002423850000285338000022938500005893440000172638000020036000051660000083367800001142452000036261400000Other non-current financial assets577690000Non-current tax assets (net)32400000Other non-current assets523710000Other current financial assets1039710000Other current assets6241050000Lease liabilities1276200000Lease liabilities657070000Other current financial liabilities1636780000Other current liabilities1726380000392390000-321030000-1541700000-1020310000-31540000-131090000003270900000445190000147910000166855000000000-950200000186180000210400000000-24415000008186800005480600000000389270000050913300000001567000000005180000592961000000000000000000000022468000001761310000-3954110000005245000000000255040000588900000847690000010770000000-1236800000-995800008200000-91380000910520000819140000Re-measurement of defined benefit plans1598000015980000Re-measurement of defined benefit plans149000001490000040200003750000Effective portion of gain/(loss) on designated portion of hedging instruments in a cash flow hedge-188960000Exchange differences on translating foreign operations38300000-150660000Effective portion of gain/(loss) on designated portion of hedging instruments in a cash flow hedge-389280000Exchange differences on translating foreign operations71930000-317350000-47560000-97980000-91140000-208220000AuditedtrueDeloitte Haskins & Sells LLPtrue2027-07-31